NYSE:MRK | Free Cash Flow | Merck & Co., Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2007-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$3.92B$991M$2.93B
2025-12-31$2.86B$1.03B$1.82B61.56%
2025-03-31$2.5B$1.33B$1.17B23.08%
2024-12-31$3.45B$937M$2.51B67.14%
2024-03-31$3.09B$861M$2.23B46.81%
2023-12-31$246M$989M-$743M
2023-03-31$1.34B$1.01B$332M11.77%
2022-12-31$4.43B$1.15B$3.28B108.75%
2022-03-31$4.76B
2021-12-31$5.1B
2021-03-31$1.79B
2020-12-31$4.01B
2020-03-31$707M
2019-12-31$4.79B
2019-03-31$1.34B
2018-12-31$3.59B
2018-03-31$1.16B
2017-12-31$4.02B
2017-03-31$286M
2016-12-31$3.63B
2016-03-31$2.17B
2015-12-31$4.25B
2015-03-31$2.28B
2014-12-31-$1.04B
2014-03-31$2.36B
2013-12-31$3.03B
2013-03-31$2.34B
2012-12-31$1.81B
2012-03-31$2.15B
2011-12-31$3.23B
2011-03-31$1.72B
2010-12-31$3.54B
2010-03-31$1.37B
2009-12-31$2.24B
2009-03-31$712.6M
2008-12-31$4B

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$16.47B$4.11B$12.36B67.71%
2024-12-31$21.47B$3.37B$18.1B105.72%
2023-12-31$13.01B$3.86B$9.14B2504.93%
2022-12-31$19.1B$4.39B$14.71B101.29%
2021-12-31$13.12B$4.45B$8.67B66.47%
2020-12-31$10.25B
2019-12-31$13.44B
2018-12-31$10.92B
2017-12-31$6.45B
2016-12-31$10.38B
2015-12-31$12.54B
2014-12-31$7.99B
2013-12-31$11.65B
2012-12-31$10.02B
2011-12-31$12.38B
2010-12-31$10.82B
2009-12-31$3.39B
2008-12-31$6.57B
2007-12-31$7B